A medical enigma: Persons with down syndrome do not develop medulloblastoma

Neuroepidemiology

Volumn 32, Issue 2, 2009, Pages 164-

  Satge D ^a   Rickert, C H ^b  

^a CENTRE HOSPITALIER   (France)

^b Department of Anatomical Pathology ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL CELL NEVUS SYNDROME; CHROMOSOME 21; DOWN SYNDROME; GERM CELL TUMOR; HUMAN; INCIDENCE; LETTER; MEDULLOBLASTOMA; NONHUMAN; SUPERNUMERARY CHROMOSOME; TERATOMA; TURCOT SYNDROME;

DOWN SYNDROME; HUMANS; MEDULLOBLASTOMA;

EID: 60149112129     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184749     Document Type: Letter

References (9)

1. Central Brain Tumor Registry of the United States: Statistical Report: Primary Brain Tumors in the United States, 1998-2002. Hinsdale, Central Brain Tumor Registry of the United States, 2005.
2. Lejeune J, Gautier M, Turpin R: Study of somatic chromosomes from 9 mongoloid children. C R Hebd Seances Acad Sci 1959;248:1721-1722.
3. Satgé D, Monteil P, Sasco AJ, Vital A, Ohgaki H, Geneix A, Malet P, Vekemans MJ, Rethore M-O: Aspects of intracranial and spinal tumors in patients with Down syndrome and report of a rapidly progressing grade 2 astrocytoma. Cancer 2001;91:1458-1466.
4. Rickert CH, Göcke H, Paulus W: Fetal ependymoma associated with Down's syndrome. Acta Neuropathol 2002;103:78-81.
5. Taylor MD: Medulloblastoma; in Tonn JC, et al (eds): Neuro-Oncology of CNS Tumors. Berlin, Springer, 2006, pp 462-478.
6. Polkinghorn WR, Tarbell NJ: Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Nat Clin Pract Oncol 2007;4:295-304.
7. Garber K: Hedgehog drugs begin to show results. J Natl Cancer Inst 2008;100:692-697.
8. Satgé D, Sasco AJ, Carlsen NLT, Stiller CA, Rubie H, Hero B, De Bernardi B, De Kraker J, Coze C, Kogner P, Langmark F, Hakvoort-Cammel FGAJ, Beck D, Von Der Weid N, Parkes S, Hartmann O, Lippens RJJ, Kamps WA, Sommelet D: A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res 1998;58:448-452.
9. Mensah A, Mulligan C, Linehan J, Ruf S, O'Doherty A, Grygalewicz B, Shipley J, Groet J, Tybulewicz V, Fisher E, Brandner S, Nizetic D: An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model. BMC Dev Biol 2007;7:31.